Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea
· Delayed Price · Currency is KRW 2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025
KOSDAQ:175250 Revenue
In the year 2025, Icure Pharmaceutical Incorporation had annual revenue of 83.38B KRW with 64.45% growth.
Revenue
83.38B
Revenue Growth
+64.45%
P/S Ratio
0.97
Revenue / Employee
379.02M
Employees
220
Market Cap
81.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 83.38B | 32.68B | 64.45% |
| Dec 31, 2024 | 50.71B | -6.10B | -10.74% |
| Dec 31, 2023 | 56.81B | -2.56B | -4.31% |
| Dec 31, 2022 | 59.37B | -4.92B | -7.65% |
| Dec 31, 2021 | 64.28B | -25.86B | -28.69% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Raphas | 30.99B |
| Coreana Cosmetics | 73.68B |
| Organic Tea Cosmetics Holdings Company | 171.42B |
| Jincostech Co.,Ltd | 17.99B |
| Nowcos | 35.64B |
| KODI CO., LTD | 76.53B |
| TS Trillion | 26.03B |
| INSAN | 35.80B |